• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核共调节因子的差异性募集指导突变型甲状腺激素受体的亚型依赖性作用。

Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.

作者信息

Fozzatti Laura, Lu Changxue, Kim Dong-Wook, Cheng Sheue-yann

机构信息

Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Drive, Bethesda, Maryland 20892-4264, USA.

出版信息

Mol Endocrinol. 2011 Jun;25(6):908-21. doi: 10.1210/me.2010-0474. Epub 2011 Apr 7.

DOI:10.1210/me.2010-0474
PMID:21474540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100599/
Abstract

Studies using mice deficient in thyroid hormone receptors (TR) indicate that the two TR isoforms, TRα1 and TRβ1, in addition to mediating overlapping biological activities of the thyroid hormone, T3, also mediate distinct functions. Mice harboring an identical dominant negative mutation (denoted PV) at the C terminus of TRα1 (Thra1(PV) mice) or β1 (Thrb(PV) mice) also exhibit distinct phenotypes. These knockin mutant mice provide an opportunity to understand the molecular basis of isoform-dependent functions in vivo. Here we tested the hypothesis that the distinct functions of TR mutant isoforms are directed by a subset of nuclear regulatory proteins. Tandem-affinity chromatography of HeLa nuclear extracts showed that distinct 33 nuclear proteins including nuclear receptor corepressor (NCoR1) and six other proteins preferentially associated with TRα1PV or TRβ1PV, respectively. These results indicate that recruitment of nuclear regulatory proteins by TR mutants is subtype dependent. The involvement of NCoR1 in mediating the distinct liver phenotype of Thra1(PV) and Thrb(PV) mice was further explored. NCoR1 preferentially interacted with TRα1PV rather than with TRβ1PV. NCoR1 was recruited more avidly to the thyroid hormone response element-bound TRα1PV than to TRβ1PV in the promoter of the CCAAT/enhancer-binding protein α gene to repress its expression in the liver of Thra1(PV) mice, but not in Thrb(PV) mice. This preferential recruitment of NCoR1 by mutant isoforms could contribute, at least in part, to the distinct liver lipid phenotype of these mutant mice. The present study highlights a novel mechanism by which TR isoforms direct their selective functions via preferential recruitment of a subset of nuclear coregulatory proteins.

摘要

使用甲状腺激素受体(TR)缺陷小鼠的研究表明,两种TR亚型,即TRα1和TRβ1,除了介导甲状腺激素T3的重叠生物学活性外,还介导不同的功能。在TRα1(Thra1(PV)小鼠)或β1(Thrb(PV)小鼠)的C末端携带相同显性负突变(称为PV)的小鼠也表现出不同的表型。这些敲入突变小鼠为了解体内亚型依赖性功能的分子基础提供了一个机会。在这里,我们测试了一个假设,即TR突变亚型的不同功能是由一部分核调节蛋白指导的。对HeLa细胞核提取物进行串联亲和层析显示,包括核受体共抑制因子(NCoR1)和其他六种蛋白质在内的33种不同的核蛋白分别优先与TRα1PV或TRβ1PV结合。这些结果表明,TR突变体对核调节蛋白的招募是亚型依赖性的。进一步探讨了NCoR1在介导Thra1(PV)和Thrb(PV)小鼠不同肝脏表型中的作用。NCoR1优先与TRα1PV相互作用,而不是与TRβ1PV相互作用。在CCAAT/增强子结合蛋白α基因启动子中,NCoR1被更强烈地招募到与甲状腺激素反应元件结合的TRα1PV上,而不是TRβ1PV上,以抑制其在Thra1(PV)小鼠肝脏中的表达,但在Thrb(PV)小鼠中则不然。突变亚型对NCoR1的这种优先招募可能至少部分导致了这些突变小鼠不同的肝脏脂质表型。本研究突出了一种新机制,即TR亚型通过优先招募一部分核共调节蛋白来指导其选择性功能。

相似文献

1
Differential recruitment of nuclear coregulators directs the isoform-dependent action of mutant thyroid hormone receptors.核共调节因子的差异性募集指导突变型甲状腺激素受体的亚型依赖性作用。
Mol Endocrinol. 2011 Jun;25(6):908-21. doi: 10.1210/me.2010-0474. Epub 2011 Apr 7.
2
NCoR1 regulates thyroid hormone receptor isoform-dependent adipogenesis.NCoR1 调节甲状腺激素受体异构体依赖性脂肪生成。
J Mol Endocrinol. 2011 Jun 9;46(3):233-44. doi: 10.1530/JME-10-0163. Print 2011 Jun.
3
Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.脂肪生成受到甲状腺激素受体突变体同工型的差异影响。
J Mol Endocrinol. 2010 Apr;44(4):247-55. doi: 10.1677/JME-09-0137. Epub 2010 Jan 15.
4
Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α.核受体共抑制因子(NCOR1)调节突变甲状腺激素受体α的体内作用。
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7850-5. doi: 10.1073/pnas.1222334110. Epub 2013 Apr 22.
5
NCOR1 modulates erythroid disorders caused by mutations of thyroid hormone receptor α1.NCOR1 调节甲状腺激素受体 α1 突变引起的红细胞疾病。
Sci Rep. 2017 Dec 22;7(1):18080. doi: 10.1038/s41598-017-18409-4.
6
Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.甲状腺激素核受体的亚型依赖性作用:来自基因敲入突变小鼠的经验教训。
Steroids. 2005 May-Jun;70(5-7):450-4. doi: 10.1016/j.steroids.2005.02.003. Epub 2005 Mar 16.
7
New insights into regulation of lipid metabolism by thyroid hormone.甲状腺激素对脂代谢调节作用的新认识。
Curr Opin Endocrinol Diabetes Obes. 2010 Oct;17(5):408-13. doi: 10.1097/MED.0b013e32833d6d46.
8
Genetic and Pharmacological Targeting of Transcriptional Repression in Resistance to Thyroid Hormone Alpha.甲状腺激素α抵抗中转录抑制的遗传和药理学靶向治疗。
Thyroid. 2019 May;29(5):726-734. doi: 10.1089/thy.2018.0399. Epub 2019 Mar 14.
9
A histone deacetylase inhibitor improves hypothyroidism caused by a TRα1 mutant.一种组蛋白去乙酰化酶抑制剂可改善由TRα1突变体引起的甲状腺功能减退。
Hum Mol Genet. 2014 May 15;23(10):2651-64. doi: 10.1093/hmg/ddt660. Epub 2013 Dec 30.
10
A targeted dominant negative mutation of the thyroid hormone alpha 1 receptor causes increased mortality, infertility, and dwarfism in mice.甲状腺激素α1受体的靶向显性负性突变导致小鼠死亡率增加、不育和侏儒症。
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):15095-100. doi: 10.1073/pnas.261565798. Epub 2001 Dec 4.

引用本文的文献

1
Nuclear receptor corepressor 1 levels differentially impact the intracellular dynamics of mutant thyroid hormone receptors associated with resistance to thyroid hormone syndrome.核受体辅阻遏子 1 水平差异影响与甲状腺激素抵抗综合征相关的突变甲状腺激素受体的细胞内动力学。
Mol Cell Endocrinol. 2024 Dec 1;594:112373. doi: 10.1016/j.mce.2024.112373. Epub 2024 Sep 17.
2
Hepatic Energy Metabolism under the Local Control of the Thyroid Hormone System.甲状腺激素系统对肝脏能量代谢的局部调控。
Int J Mol Sci. 2023 Mar 2;24(5):4861. doi: 10.3390/ijms24054861.
3
Kinesins Modify ERR1-Dependent Transcription Using a Conserved Nuclear Receptor Box Motif.驱动蛋白利用保守的核受体盒基序修饰 ERR1 依赖性转录。
Int J Mol Sci. 2023 Feb 14;24(4):3795. doi: 10.3390/ijms24043795.
4
Thyroid Hormone Receptor Beta as Tumor Suppressor: Untapped Potential in Treatment and Diagnostics in Solid Tumors.甲状腺激素受体β作为肿瘤抑制因子:实体瘤治疗与诊断中的未开发潜力
Cancers (Basel). 2021 Aug 24;13(17):4254. doi: 10.3390/cancers13174254.
5
A Direct Comparison of Thyroid Hormone Receptor Protein Levels in Mice Provides Unexpected Insights into Thyroid Hormone Action.在小鼠中直接比较甲状腺激素受体蛋白水平为甲状腺激素作用提供了意想不到的见解。
Thyroid. 2020 Aug;30(8):1193-1204. doi: 10.1089/thy.2019.0763. Epub 2020 Apr 6.
6
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.BETi 联合 MEKi 增强甲状腺未分化癌的抗肿瘤作用。
Endocr Relat Cancer. 2019 Sep;26(9):739-750. doi: 10.1530/ERC-19-0107.
7
Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors.BET和MEK抑制剂的协同作用促进间变性甲状腺肿瘤消退。
Oncotarget. 2018 Oct 23;9(83):35408-35421. doi: 10.18632/oncotarget.26253.
8
Nongenomic actions of thyroid hormone.甲状腺激素的非基因组作用。
Nat Rev Endocrinol. 2016 Feb;12(2):111-21. doi: 10.1038/nrendo.2015.205. Epub 2015 Dec 15.
9
Thyroid hormone receptor α mutation causes a severe and thyroxine-resistant skeletal dysplasia in female mice.甲状腺激素受体α突变在雌性小鼠中导致严重的甲状腺素抵抗性骨骼发育不良。
Endocrinology. 2014 Sep;155(9):3699-712. doi: 10.1210/en.2013-2156. Epub 2014 Jun 10.
10
Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer.核受体共抑制因子(NCOR1)在甲状腺癌小鼠模型中的致癌作用。
PLoS One. 2013 Jun 26;8(6):e67954. doi: 10.1371/journal.pone.0067954. Print 2013.

本文引用的文献

1
Adipogenesis is differentially impaired by thyroid hormone receptor mutant isoforms.脂肪生成受到甲状腺激素受体突变体同工型的差异影响。
J Mol Endocrinol. 2010 Apr;44(4):247-55. doi: 10.1677/JME-09-0137. Epub 2010 Jan 15.
2
Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.细胞周期与凋亡调节因子1对Wnt和β-连环蛋白激活靶基因以及人结肠癌细胞非锚定依赖性生长的需求。
J Biol Chem. 2009 Jul 31;284(31):20629-37. doi: 10.1074/jbc.M109.014332. Epub 2009 Jun 11.
3
Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms.未结合配体的甲状腺激素受体亚型对脂质代谢的独特失调作用。
Mol Endocrinol. 2009 Mar;23(3):308-15. doi: 10.1210/me.2008-0311. Epub 2009 Jan 8.
4
CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes.CCAR1,一种介导复合物募集至核受体转录复合物的关键调节因子。
Mol Cell. 2008 Aug 22;31(4):510-519. doi: 10.1016/j.molcel.2008.08.001.
5
Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation.核受体共调节因子:细胞调控的评判者、陪审团和行刑者
Mol Cell. 2007 Sep 7;27(5):691-700. doi: 10.1016/j.molcel.2007.08.012.
6
Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.由突变的甲状腺激素α1受体引起的脂肪生成受损。
Mol Cell Biol. 2007 Mar;27(6):2359-71. doi: 10.1128/MCB.02189-06. Epub 2007 Jan 12.
7
Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone beta receptor inhibits mitotic progression.由突变的甲状腺激素β受体诱导的PTTG1异常积累会抑制有丝分裂进程。
J Clin Invest. 2006 Nov;116(11):2972-84. doi: 10.1172/JCI28598. Epub 2006 Oct 12.
8
Characterization of skeletal phenotypes of TRalpha1 and TRbeta mutant mice: implications for tissue thyroid status and T3 target gene expression.TRα1和TRβ突变小鼠骨骼表型的特征:对组织甲状腺状态和T3靶基因表达的影响
Nucl Recept Signal. 2006;4:e011. doi: 10.1621/nrs.04011. Epub 2006 Jul 7.
9
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.突变型甲状腺激素β受体对磷脂酰肌醇3激酶信号通路的激活作用。
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1780-5. doi: 10.1073/pnas.0510849103. Epub 2006 Jan 30.
10
Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor alpha1 or beta.针对甲状腺激素受体α1或β的相同突变小鼠的对比骨骼表型。
Mol Endocrinol. 2005 Dec;19(12):3045-59. doi: 10.1210/me.2005-0224. Epub 2005 Jul 28.